Canine Heartworm Disease: Prevention, Diagnosis, and Treatment

Introduction

Canine heartworm disease is a potentially fatal parasitic condition caused by the filarial nematode Dirofilaria immitis [1, 2]. The disease is transmitted through the bite of infected mosquitoes of the family Culicidae, which serve as obligate intermediate hosts [3, 4]. Dirofilaria immitis primarily infects canids, including domestic dogs and wild canids such as coyotes, and has been documented in an expanding geographic range due to climatic and vector shifts [2, 5, 6]. The presence of Wolbachia endosymbionts within D. immitis plays a critical role in parasite biology and host inflammatory responses [1]. Understanding the intricate biology of the parasite, the host-pathogen interactions, and the evolution of resistance to preventive agents is essential for effective clinical management [7, 8, 9].

Etiology and Life Cycle

Dirofilaria immitis belongs to the family Onchocercidae and exhibits a typical heteroxenous life cycle requiring both a definitive canid host and a mosquito vector [3, 4]. Adult worms reside in the pulmonary arteries and right ventricle of the heart, where females produce microfilariae that circulate in the peripheral blood [10, 11]. Mosquitoes ingest microfilariae during a blood meal; the larvae develop through two molts within the Malpighian tubules to the infective third stage (L3). Infective L3 larvae are transmitted to a new host during a subsequent blood meal. Development to adult worms in the dog takes approximately 6 to 7 months [12, 13]. The extrinsic incubation period within the mosquito is temperature dependent and is projected to shorten under climate change scenarios, thereby expanding transmission potential [6].

Molecular characterization of isolates has revealed genetic diversity and population structure that may influence virulence and drug susceptibility [5, 8]. Population genomics suggests an ancient origin of heartworms in canids, with contemporary populations exhibiting signatures of selection relevant to anthelmintic resistance [8]. The glutamate-gated chloride channel (GLC-2) has been characterized as a molecular target for macrocyclic lactones, and mutations in this channel are associated with resistance [14, 9].

Clinical Signs and Pathophysiology

Clinical manifestations of canine heartworm disease correlate with the worm burden, duration of infection, and host immune response [15, 16]. In the early stages, dogs may be asymptomatic. As disease progresses, exercise intolerance, cough, dyspnea, and syncopal episodes become evident [17, 18]. Severe infection can lead to right-sided congestive heart failure, caval syndrome, and sudden death [19]. The presence of adult worms in the pulmonary arteries causes endothelial damage, intimal proliferation, and pulmonary hypertension [15, 20]. Microfilaremic dogs often exhibit elevated haptoglobin concentrations, reflecting systemic inflammation [21]. Coinfections with other vector-borne pathogens, such as Babesia spp., are common and may complicate clinical presentation [12, 22]. Renal pathology has also been documented in Dirofilaria repens infections, but similar findings may occur with D. immitis [16]. Unusual presentations include ectopic worm migration to the bronchial tree or hernia sacs [23, 19].

Diagnostics

Accurate diagnosis of canine heartworm disease relies on a combination of antigen testing, microfilaria detection, and ancillary methods. Circulating antigen testing using commercial ELISA kits detects adult female worm antigens and exhibits high sensitivity and specificity in clinically suspected populations [24, 25]. Point-of-care immunochromatographic tests have been validated against the modified Knott’s test, with comparative performance data available [26, 25]. Bayesian latent class modeling has been employed to estimate test accuracy in the absence of a perfect gold standard [25].

Microfilaria detection methods include the modified Knott’s test and direct wet-mount examination, which can differentiate D. immitis from D. repens and other filariids based on morphometric criteria [26, 10, 27]. Molecular diagnostics such as loop-mediated isothermal amplification (LAMP) targeting the cytochrome c oxidase subunit I (COI) gene offer high sensitivity and specificity for field and laboratory applications [28]. Droplet digital PCR (ddPCR) assays have been developed to detect single nucleotide polymorphisms associated with macrocyclic lactone resistance, providing a tool for monitoring emerging resistance [9].

Thoracic radiography and echocardiography are valuable for assessing pulmonary artery enlargement, right ventricular hypertrophy, and visualizing adult worm bundles in the pulmonary arteries or heart chambers [20, 29]. Ultrasound imaging has been described for detecting mobile worms in unusual locations [29].

Treatment

Treatment of canine heartworm disease aims to eliminate adult worms (adulticide therapy) while managing thromboembolic complications. The traditional adulticide protocol using melarsomine dihydrochloride remains the standard of care in many regions, but concerns about availability, toxicity, and resistance have prompted investigation of alternative protocols [30, 7]. A systematic review and meta-analysis of non-arsenical adulticide protocols using moxidectin and doxycycline demonstrated efficacy in clearing adult worms, particularly when combined with sustained-release injectable formulations [30]. Doxycycline targets the Wolbachia endosymbionts, leading to reduced filarial fecundity and enhanced adult worm susceptibility to macrocyclic lactones [1, 30, 19].

Macrocyclic lactone resistance in D. immitis has been documented, and molecular markers for resistance are being characterized using ddPCR [9]. The emergence of resistance underscores the need for routine susceptibility testing and adherence to year-round preventive protocols [7]. Complications during treatment, such as pulmonary thromboembolism, require careful case management with exercise restriction and anti-inflammatory therapy [19]. Rare cases of hemoptysis with expectoration of adult worms have been reported after doxycycline-moxidectin treatment [19].

Prevention and the Role of Combination Heartworm and Flea Control Products

Prevention of canine heartworm disease relies on continuous administration of macrocyclic lactone endectocides, including ivermectin, moxidectin, and selamectin. These agents act as glutamate-gated chloride channel agonists, causing flaccid paralysis and death of larval stages [31, 32, 14]. Sustained-release injectable moxidectin formulations have demonstrated high efficacy in endemic areas [31]. Novel oral combination products containing lotilaner, moxidectin, praziquantel, and pyrantel provide simultaneous prevention of heartworm, flea, and gastrointestinal parasite infections [32].

The concept of a dog heartworm and flea pill has become a cornerstone of integrated parasitic control. These oral combination formulations simplify owner compliance by delivering a single chewable tablet that protects against both D. immitis and fleas (Ctenocephalides felis). The inclusion of isoxazolines (e.g., lotilaner) targets the flea GABA receptor, while the macrocyclic lactone component prevents heartworm larval development [32]. Promoting year-round use of such combination products reduces the risk of gaps in prevention and mitigates the impact of resistance selection [7].

In addition to chemoprophylaxis, mosquito control measures such as reducing standing water and using environmental insecticides complement heartworm prevention strategies [4]. The expanding geographic range of heartworm due to climate change necessitates increased vigilance in previously low-risk areas [6].

mermaid graph TD A[Clinical suspicion or routine screening], > B{Antigen test (ELISA)} B, >|Positive| C{Microfilaria test (Knott's)} B, >|Negative| D[Consider low worm burden or recent infection] C, >|Positive| E[Confirm D. immitis infection] C, >|Negative| F[Occult infection - consider PCR or ultrasound] E, > G{Assess severity} G, >|Mild/Moderate| H[Adulticide therapy (melarsomine or moxidectin/doxycycline)] G, >|Severe/Caval syndrome| I[Stabilization and careful adulticide] H, > J[Post-treatment management: exercise restriction, monitoring] F, > K[Repeat antigen test in 3-6 months or use PCR] D, > K I, > J J, > L[Year-round prevention program including heartworm flea pill]

References

[1] Loku Gamage N, Ranasinghe K, Rodrigo W. Molecular Characterization of Wolbachia Endosymbionts and Their Association With Canine Dirofilariasis in Colombo District, Sri Lanka. J Parasitol Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42328691/

[2] Leaman LJ, Graham KF, Jones MEB et al. First reported case of Dirofilaria immitis in a coyote (Canis latrans) from Prince Edward Island. Can Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42266338/

[3] Amarasinghe S, Ranasinghe K, Rodrigo W et al. First molecular characterization of Dirofilaria vector species and the distribution of canine dirofilariasis in Gampaha district, Sri Lanka. Front Cell Infect Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42064220/

[4] Hammond NG, Todaro A, Fairbanks KA et al. Mosquito (Diptera: Culicidae) surveillance for Dirofilaria immitis (Rhabditida: Onchocercidae) using a zoo as a focus for operational detection in central Utah. J Med Entomol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41723581/

[5] Monteiro ACMP, Ribeiro CM, Fehlberg HF et al. Emergence of Dirofilaria immitis in humid coastal zones: Epidemiological predictors and molecular characterization. Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41990946/

[6] Atkinson PJ, Nielsen TD, Caraguel C. Historical and Projected Impact of Global Climate Change on the Extrinsic Incubation of Dirofilaria immitis. Ecol Evol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41409073/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[7] Geary TG. Current issues in heartworm chemotherapy. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41851772/

[8] Power RI, Abdullah S, Walden HS et al. Population genomics reveals an ancient origin of heartworms in canids. Commun Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41559308/

[9] Kumar S, Lalicon IK, Prichard RK et al. Development and evaluation of quadruplex droplet digital PCR assay for rapid detection of molecular markers associated with macrocyclic lactone resistance and susceptibility in Dirofilaria immitis. Int J Parasitol Drugs Drug Resist. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41558254/

[10] Roya GM, Yagoob G, Bahram AT. Seasonal study of Blood Parasites: Dirofilaria immitis and Dipetalonema reconditum in the Guard Dogs of Tabriz city, Iran. Arch Razi Inst. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41769291/

[11] Nakhale M, Hess JA, Oliver E et al. Development of Dirofilaria immitis adult worms in NSG mice, detection of parasite-derived microRNA and comparative analysis of laboratory isolates. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41617897/

[12] Ranahewa DK, Dangolla A, Rajakaruna RS et al. Subclinical Infections of Babesia and Dirofilaria in Dogs Presented to a Veterinary Teaching Hospital: Evidence for a Silent Reservoir of Infection in Sri Lanka. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42113286/

[13] Moreira SMK, Moreira AVC, Uquillas CAM et al. Morpho-molecular identification of heartworms (Dirofilaria immitis) in domestic dogs in the Sucre canton, Ecuador. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41453721/

[14] Nichols J, Forrester SG. Isolation and characterization of a novel glutamate-gated chloride channel subunit (GLC-2) from the canine heartworm Dirofilaria immitis. Mol Biochem Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41581768/

[15] Kim M, Seo M, Cho J et al. Clinicopathologic variables according to disease severity in dogs with heartworm disease. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42152057/

[16] Szabó KÉ, Aresu L, Müller L et al. Clinico-pathological and renal morphological findings in dogs naturally infected with Dirofilaria repens. BMC Vet Res. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42069630/

[17] Safdar I, Ur Rehman S, Roman U et al. Serological and molecular detection of Dirofilaria immitis in pet dogs of Lahore, Pakistan. Ann Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41881496/

[18] Zanfagnini LG, Chocobar MLE, Schmidt EMS et al. Unveiling filariid infections in dogs living in the Western Amazon, Brazil. Comp Immunol Microbiol Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41818949/

[19] Nogueira LLDC, Araújo BVS, Antunes JMAP et al. Blood bronchial mucus with Dirofilaria immitis adult worms after the treatment with doxycycline and moxidectin: a rare case presentation. Parasitology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41549761/

[20] Stokowski S, Steuri SK, Lux C et al. Gastric Dilatation and Volvulus and Heartworm Disease in a Dog With Situs Inversus. Vet Radiol Ultrasound. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42011803/

[21] Chocobar MLE, Eckersall DP, Panarese R et al. Comparison of Haptoglobin Concentrations Between Microfilaremic and Amicrofilaremic Dogs Infected by Dirofilaria immitis. Vet Clin Pathol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41612543/

[22] Julca LA, Salas-Fajardo MY, Guevara S et al. Seroprevalence of zoonotic vector-borne pathogens in domestic dogs from rural areas in northern Peru. Top Companion Anim Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42035833/

[23] Rajković M, Rajković V, Bogunović D. Dirofilaria immitis and Dirofilaria repens co-infection in a microfilaremic dog from Negotin, Eastern Serbia: Unusual localization of adult Dirofilaria repens in an abdominal hernia sac. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741045/

[24] Nonnis F, Corda A, Zeinoun P et al. Feline heartworm disease in endemic settings: an integrated diagnostic approach. Res Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42225012/

[25] Atkinson PJ, Quimby C, Datt A et al. Relative accuracy of point-of-care tests to rule-in heartworm infection in clinically suspected dogs using Bayesian latent class modelling. Prev Vet Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41520422/

[26] Sanders TL, Starnes A, Kelly MA et al. Comparative performance of the novel, point-of-care Pluslife Mini Dock Dirofilaria immitis/Dirofilaria repens detection test with the modified Knott's test in dogs. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42104384/

[27] Santhosh K, Preena P, Sarangom SB et al. Microfilaruria of morphologically identified Dirofilaria repens and Brugia spp. in one cat and two dogs: Case series. Top Companion Anim Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41448351/

[28] Genc MG, Erol U, Sahın OF et al. Application of COI-LAMP for Detection of Dirofilaria immitis with High Sensitivity and Specificity in Epidemiological Studies. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41801609/

[29] Malghem J, Vande Berg B, Lengelé B et al. Dirofilaria repens Parasite: Review with Emphasis on Ultrasound Findings with Looking for Worm Mobility. J Belg Soc Radiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41909165/

[30] Santiwattanatarm T, Sakcamduang W, Kongkaew C et al. A systematic review and meta-analysis of non-arsenical adulticide protocols using moxidectin and doxycycline for the treatment of adult heartworm infection in dogs. Curr Res Parasitol Vector Borne Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42007372/

[31] Genchi M, Venco L, Fozzer M et al. Efficacy and safety of a sustained-release formulation of ivermectin (FILAPREV) in preventing heartworm infection (Dirofilaria immitis) in dogs in two endemic areas of Italy. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42087229/

[32] Young L, Reinemeyer CR, Abdelmoneim M et al. Efficacy of a novel chewable tablet (Credelio Quattro) containing lotilaner, moxidectin, praziquantel, and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasit Vectors. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41943128/

[33] Aguilar-Elena R, Rodríguez-Escolar I, Collado-Cuadrado M et al. Global Research Trends in Emerging Zoonosis Due to (the Filarial Nematode) Dirofilaria repens (1955-2025): A Bibliometric Analysis of a Climate-Driven Expansion. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42075713/

[34] Martínez-Durán D, Mujika M, Morales M et al. Vector-borne pathogens in Spanish greyhounds from Central Spain: Prevalence and hematobiochemical findings. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41741046/

[35] Nagy E, Nagy RR, Csivincsik Á et al. Unusually low infection rate of Dirofilaria immitis in its wildlife hosts by the northern border of the Mediterranean climate zone in Hungary. Front Vet Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41487481/